不想要在35岁的时候.

Same author

Familial juvenile hyperuricaemic nephropathy is not such a rare genetic metabolic purine disease in Britain.

Nucleosides, nucleotides & nucleic acids·2006

Same author

The discovery of diabetic nephropathy: from small print to centre stage.

Journal of nephrology·2006

Same author

Familial juvenile hyperuricaemic nephropathy.

QJM : monthly journal of the Association of Physicians·2004

Same author

Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease.

QJM : monthly journal of the Association of Physicians·2002

Same author

Characteristics and outcome of membranous nephropathy in older patients.

International urology and nephrology·2002

Same author

The continued care of children with renal disease into adult life.

Pediatric nephrology (Berlin, Germany)·2001

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

相关实验视频

不想要在35岁的时候.

相关概念视频

Familial juvenile hyperuricaemic nephropathy is not such a rare genetic metabolic purine disease in Britain.

The discovery of diabetic nephropathy: from small print to centre stage.

Familial juvenile hyperuricaemic nephropathy.

Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease.

Characteristics and outcome of membranous nephropathy in older patients.

The continued care of children with renal disease into adult life.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

不想要在35岁的时候.

相关概念视频

相关文章

Familial juvenile hyperuricaemic nephropathy is not such a rare genetic metabolic purine disease in Britain.

The discovery of diabetic nephropathy: from small print to centre stage.

Familial juvenile hyperuricaemic nephropathy.

Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease.

Characteristics and outcome of membranous nephropathy in older patients.

The continued care of children with renal disease into adult life.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.